It was found that GLDC was overexpressed in non-small cell lung cancer stem cells and could enhance the tumorigenic ability of non-small cell lung cancer stem cells by enhancing glycolysis and pyrimidine metabolism (Zhang et al, 2012). This evidence concerns the gene GLDC and small cell lung carcinoma.